Pharma News

Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.

Ambys Medicines and Takeda Announce Partnership to Pioneer First-in-Class Therapies for the Treatment of Serious Liver Diseases

Thursday, August 09, 2018

Ambys Medicines a biotechnology company focused on the discovery and development of transformative therapies for people with serious liver disease and Takeda Pharmaceutical Company Limited Takeda announced today that they have entered into a partners...

Carolina BioOncology (CBI) enters into an Agreement with Xcell Biosciences (XcellBio) for Advanced Immunotherapeutic Development

Thursday, August 09, 2018

XcellBio a proprietary provider of primary cell control technologies for immunotherapeutic solutions today announced a collaboration with Carolina BioOncology Institute CBI to further preclinical development of true personalized medicine therapies CB...

Tanner Pharma Group Signs Distribution Agreement with Nephcentric LLC

Wednesday, August 08, 2018

Tanner Pharma Group Tanner a global provider of integrated specialty access solutions has announced the signing of a distribution agreement with Nephcentric LLC Nephcentric a developer and marketer of evidence based therapeutic options for people wit...

Synergy Pharmaceuticals Announces License Agreement with Luoxin Pharmaceutical Group for TRULANCE® (plecanatide) in China

Wednesday, August 08, 2018

Synergy Pharmaceuticals Inc announced today that the company has entered into a license agreement with Luoxin Pharmaceutical Group Co Ltd Shandong Luoxin providing Luoxin exclusive rights to develop and commercialize Synergys lead product TRULANCE pl...

Alteogen Gets FDA Approval for Orphan Drug Designation with an Antibody-Drug Conjugate for Gastric Cancer

Tuesday, August 07, 2018

Alteogen Inc announced that it has successfully got an approval for orphan drug designation from the US Food and Drug Administration FDA with one of its assets ALTP for gastric cancer designation letter last week ALTP is an antibodydrug conjugate AD...

ACADIA Pharmaceuticals and Neuren Pharmaceuticals Announce Exclusive License Agreement

Tuesday, August 07, 2018

ACADIA Pharmaceuticals Inc and Neuren Pharmaceuticals Limited announced today that they have entered into an exclusive North American License Agreement for the development and commercialization of trofinetide for Rett syndrome and other indications N...

Selumetinib Granted Orphan Designation in Europe for Neurofibromatosis Type 1

Monday, August 06, 2018

AstraZeneca and Merck known as MSD outside the US and Canada today announced that the European Medicines Agency EMA has granted orphan designation to selumetinib a MEK inhibitor for the treatment of neurofibromatosis type NF NF is an incurable...

Salix Expands Microbiome Research And Discovery Through Strategic Collaboration With Cedars-Sinai Medical Center

Saturday, August 04, 2018

Salix Pharmaceuticals a leading specialty pharmaceutical company committed to the prevention and treatment of gastrointestinal GI disorders and a wholly owned subsidiary of Bausch Health Companies Inc today announced its affiliate has entered into a...

Akcea Therapeutics and PTC Therapeutics Collaborate to Commercialize Two Rare Disease Drugs in Latin America

Friday, August 03, 2018

PTC Therapeutics Inc and Akcea Therapeutics Inc an affiliate of Ionis Pharmaceuticals Inc today announced a collaboration under which PTC will commercialize two of Akceas rare disease drugs in Latin America TEGSEDIand WAYLIVRA TEGSEDI has received...

Tanner Pharma Group Signs Distribution Agreement with MannKind Corporation

Friday, August 03, 2018

Tanner Pharma Group Tanner a global provider of integrated specialty access solutions has announced the signing of a distribution agreement with MannKind Corporation a biopharmaceutical company focused on inhaled therapeutic products for patients wit...